Pharmacy Report Archives - Page 39 of 150 - Becker's Hospital Review

Hospitals prep for IV fluid shortages | The 73 drugs Baxter's NC site makes | Texas sues PBMs, drugmakers: 5 notes | Hospitals to CMS: Extend prescribing flexibilities | Zepbound shortage ends

October 7, 2024 BHR Newsletter 1. Hospitals prepare for months-long supply disruptions after Helene, port strike Full story 2. The 73 drugs made at Baxter's flooded site Full story 3. Kroger sells specialty pharmacy unit to Elevance Full story 4.…

After $40M settlement, drug trial continues | CMS edits drug price talks | 10 systems seeking pharmacy leaders | La. restricts abortion pill access | Ozempic as an addiction therapy: 4 notes

October 3, 2024 BHR Newsletter 1. CMS tweaks drug price negotiations for 2025 Full story 2. After $40M settlement, Alzheimer's drug under scrutiny as human trials proceed Full story 3. Ozempic as an addiction treatment: 4 notes Full story 4. Don't risk losing to…

CVS' potential breakup: 3 notes | Payer to offer $0 Humira biosimilar: 7 notes | Drug co. pays $40M to settle case | Mass. system exits bankruptcy | An overlooked drug for C. diff

October 2, 2024 BHR Newsletter 1. Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro Full story 2. Why a CVS breakup may be hard to execute: 3 notes Full story 3. Blue Shield of California's zero-dollar biosimilar strategy:…

CVS board mulls breakup | The future of pharmacy leadership: 7 execs | 1 year post-'pharmageddon': 4 notes | FDA panel votes to restrict cancer drugs | McLaren closes clinics in Walgreens

October 1, 2024 BHR Newsletter 1. UPMC leader: 'We're running out of levers in pharmacy to manage costs' Full story 2. FDA approves drug for thyroid cancer treatment Full story 3. Unionization picks up after 'pharmageddon': 4 things to know…

J&J cancels 340B rebate plan | CVS to lay off 2,900: 4 notes | Main US supplier of IV solutions halts production | FDA approves schizophrenia drug | Systems abandon rigid hierarchies

September 30, 2024 BHR Newsletter 1. J&J to forgo 340B rebate plan implementation Full story 2. Nation's largest supplier of IV solutions temporarily closes amid Helene Full story 3. Investors sour on CVS Health, layoffs announced: 4 notes Full story 4.…

Pfizer withdraws drug: What to know | Mark Cuban's advice to employers | 10 systems seeking pharmacy leaders | Rx delay led to patient death: Study | 5 Ozempic updates

September 26, 2024 BHR Newsletter 1. Pfizer pulls sickle cell disease drug from market Full story 2. Mark Cuban to employers: Save millions with 1 move Full story 3. FDA eyes 1st schizophrenia drug in decades: 5 things to know…

AI finds new uses for old meds | 10 of 20 popular drugs in shortage | FDA to probe tumor tests | 25 priciest hospital drugs | Pay cuts, layoffs hit the C-suite

September 25, 2024 BHR Newsletter 1. AI finds new uses for old drugs: Harvard study Full story 2. 25 most expensive hospital drugs Full story 3. What does the 'average' health system look like? Full story 4. Don't risk losing…

8 new drug shortages | 15 largest US pharmacies | Hundreds of Merck drug lawsuits revived | Which meds might face CMS price talks | FTC's lawsuit against PBMs: 9 notes

September 24, 2024 BHR Newsletter 1. Federal court revives hundreds of lawsuits over osteoporosis drug Full story 2. 8 drugs now in shortage Full story 3. The nation's 15 biggest pharmacies Full story 4. Prescriptions continue to be a key…

What's next for hospital pharmacies: 4 execs | Potential uses for metformin | FDA clears at-home flu vaccine | 10 fastest-growing C-suite roles | Old painkillers superior to new migraine meds: Study

September 23, 2024 BHR Newsletter 1. What's next for hospital pharmacies? 4 leaders weigh in Full story 2. FDA approves 1st self-administered flu vaccine Full story 3. Studies point to 2 potential new metformin uses Full story 4. Pharmacists are…

Zantac trial ends in hung jury | CVS subsidiary settles kickback claims | La. pharmacists prep for new mifepristone rule | 10 systems seeking pharmacy leaders | Tenet's outpatient boom

September 19, 2024 BHR Newsletter 1. For $60M, CVS' Oak Street Health settles kickback allegations Full story 2. 313 quietest hospitals Full story 3. Louisiana hospitals, pharmacists prep for abortion pill rule changes Full story 4. Virtual care — the…